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Summary
Objectives: To deﬁne, for the C5.18 chondrocyte-restricted rat cell line, (1) the capacities for recognition of alternatively spliced segments of
the adhesion protein ﬁbronectin (FN), (2) the integrin subunits required for such recognition, and (3) differences in such FN recognition vs the
multipotential chondroprogenitor line, RCJ 3.1.
Methods: C5.18 and RCJ 3.1 cells were tested for their capacities to adhere to recombinant alternatively spliced segments of rat FN, pre-
sented on plastic surfaces either in isolation or in partial FNs spanning the 7th through 15th type III repeats (III7-15 FNs). The effects on
such adhesion of cations and integrin subunit-speciﬁc antibodies were tested.
Results: Despite signiﬁcant augmentation in chondrocyte-speciﬁc gene expression in C5.18 relative to the RCJ 3.1 cells, the two lines
exhibited similar recognition of FN spliced segments and partial isoforms. Speciﬁcally, both lines adhered to the extra type III repeat A (EIIIA)
and V, but not extra type III repeat B (EIIIB), segments. There were different cation and integrin subunit requirements for adhesion to EIIIA vs
V segments, and only the V segment was recognized in the context of a III7-15 FN. Such recognition was mediated via a ‘‘second’’ argininee
glycineeaspartic acid (RGD) sequence that is present in the V95 subsegment in rat, but not human, FN.
Conclusion: The chondrocyte lineage-committed C5.18 cell line, similar to its multipotential chondroprogenitor, RCJ 3.1, recognizes the
‘‘cartilage-restricted’’ EIIIA and V segments of FN with cation, integrin, and molecular context requirements that are speciﬁc to each of these
segments.
Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
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The molecular composition of the extracellular matrix (ECM)
in chondrogenic tissues varies across embryonic develop-
ment, potentially providing signals for cells to proceed
through speciﬁc phases of differentiation. Included among
such components are members of the ﬁbronectin (FN)
family of adhesion proteins1e5. Although encoded by a sin-
gle gene, FN pre-messenger RNA (mRNA) is subject to al-
ternative splicing at three sites, corresponding with the extra
type III repeat B (EIIIB), extra type III repeat A (EIIIA) and V
segments (Fig. 1). The former two of these are w90 amino
acid type III repeat structures, which may either be wholly
included or excluded. In contrast, the V region does not
conform with a repeating module and is subject to partial
or total inclusion6,7. The ﬁnding that soluble FN fragments
regulate chondrocyte gene expression, whereas full-length
FN does not, indicates that FN structure is critical to its
interactions with chondrocytes8e11, and reinforces the*Address correspondence and reprint requests to: J. H. Peters,
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228concept that alternative splicing could regulate FNechon-
drocyte interactions.
While all three spliced segments of FN are widely co-ex-
pressed in the early embryo, EIIIA expression ceases in
precartilaginous cell condensations near the time of chon-
drogenesis4,5. Cartilage is also the only tissue in which
splicing can exclude the V segment together with the adja-
cent 15th type III and 10th type I repeats, accounting for
w80% of FNs in mature cartilage6,12. To test the hypothesis
that the ‘‘cartilage-restricted’’ EIIIA and/or V segments could
be poorly compatible with differentiated chondrocyte func-
tion or cartilage matrix structure in vitro will require systems
in which these segments are recognized by cells that are
subject to chondrocytic differentiation, and for which the
conditions for such recognition have been established.
A potential barrier to the development of cell-based sys-
tems to study chondrocyte differentiation and chondrogene-
sis is that differentiated and terminally differentiated
chondrocyte phenotypes are unstable in vitro. An exception
to this rule is the nontransformed chondrocyte-restricted rat
cell line RCJ 3.1C5.18 (C5.18), which expresses differenti-
ated and terminally differentiated chondrocyte phenotypes
in a sequence that mimics chondrocytes in the endochon-
dral growth plate13,14. Therefore, the C5.18 line potentially
constitutes a system with which to examine the effects of
Fig. 1. Recombinant rat FNs. Type I, II, and III repeats are depicted as rectangles, circles, or squares in the schematic rat FN monomer at the
top of the ﬁgure. Labeled pointers identify the EIIIB, III-10 (10th type III repeat), EIIIA, and V segments. RGD sequences in III-10 and in the V95
subsegment are depicted as large dots. To the right below this are the two sets of recombinant III7-15 partial FNs containing (Rþ) or not con-
taining (R) the RGD sequence in III-10. Single FN segments are depicted below this. To the left are ELISA dose-response curves document-
ing absorbance to plastic of recombinant Rþ and R III7-15 partial FNs, as well as single FN segment glutathione S-transferase (GST) fusion
proteins, all at coating concentrations of 0.4, 2, 10, 200, and 1000 nM. ELISAs were performed either with anti-GST (left panels, data represent
the average of 4 assays) or anti-his (right panels, average of three assays) antibodies to detect plastic-bound III7-15 constructs (doubly tagged
with N-terminal GST and C-terminal his), whereas only anti-GST antibodies were used for FN segments, each of which contained single
N-terminal GST tag. Note that increasing protein coating concentrations are associated with increases in optical density signals for each re-
combinant FN and for GST as detected by an anti-GST antibody, but not for phosphate-buffered saline (PBS). EC50 values for Rþ III7-15
constructs, ordered SM, Bþ, Aþ and Vþ, were 17.4 15.2, 21.1 13.1, 17.1 14.6, and 74.2 30.6 nM with anti-GST, and 7.4 4.2,
7.1 4.0, 4.6 4.1, and 4.8 4.1 nM with anti-his antibodies. Corresponding values for R constructs were 70.6 9.8, 91.4 18.1,
47.4 26.7, and 9.7 0.1 with anti-GST, and 4.8 4.1, 9.6 0.2, 2.4 0.1, and 1.8 0.2 nM with anti-his antibodies.
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ation. We have used cell adhesion assays to determine that
C5.18 cells recognize the EIIIA and V, but not EIIIB, seg-
ments of FN. Despite a relative lack of chondrocyte-speciﬁc
gene expression, the RCJ 3.1 multipotential chondroproge-
nitor cell line from which C5.18 cells were originally derived
exhibited FN recognition that was generally similar to C5.18
cells, suggesting that acquisition of such gene expression
may not be tightly associated with a cell’s capacity to recog-
nize speciﬁc FN structural moieties.
MethodsCELL CULTUREC5.18 and RCJ3.1 cell lines were cultured in monolayer, passaged, and re-
plated as described15 except that dexamethasone and ascorbic acid were not
added to RCJ3.1 medium. Following proteolytic release, cell suspensions
were washed with 0.5 mg/ml soy bean trypsin inhibitor (Sigma) and counted
in serum-freealpha-MEMþ 1%bovine serumalbumin (BSA) prior to cell adhe-
sion assays.SYNTHETIC PEPTIDES, FUSION PROTEINS, AND RAT PLASMA
FN (pFN)Glycine-arginine-glycine-aspartic acid-serine-proline (GRGDSP) and
glycine-arginine-glycine-glutamic acid-serine-proline (GRGESP) with high
performance liquid chromatography (HPLC) purity> 98% were purchased
from Anaspec Inc., San Jose, CA. EILDV (HPLC purity >97%) was from
Bachem, Torrance, CA. EIIIB-GST, EIIIA-GST, III-10-GST, V-GST and
GST fusion proteins, each containing an N-terminal GST, were cloned,
sequenced, expressed, and puriﬁed as described5,16. Recombinant III7-15
partial FNs, containing one or no spliced segments, and with or without de-
letion of the RGD sequence in III-1017 (Fig. 1) were cloned as described18
and generously provided as glycerol stocks by Richard Hynes of M.I.T,
Cambridge, MA. All constructs were doubly puriﬁed via sequential histidine
(his) followed by GST-tag afﬁnity isolation as described18, except that the im-
idazole concentration for elution of the Ni-NTA agarose (Qiagen, Valencia,
CA) column was 250 mM. Proteins were quantitated using bicinchoninic
acid (BCA) reagent (Pierce, Rockford, Il) and purity and spliced segment
content was conﬁrmed by sodium dodecyl sulfate (SDS)-PAGE and western
immunoblot analysis using rabbit antisera to EIIIB-maltose-binding protein or
to V95 subsegment fusion protein to detect the EIIIB and V segments re-
spectively, or MAb 15/27 to detect EIIIA5,16. Rat pFN was from GIBCO/
BRL (Grand Island, NY). Proteins and peptides were stored in aliquots at
75C prior to use.
230 C. Fernandez et al.: Recognition of the alternatively spliced segments of FNANTIBODIESAntisera to rat pFN and to the V95 subsegment of rat FN5, as well as MAb
8B3 vs aV integrin subunit19 were generous gifts from Dr. Richard O. Hynes.
Additional anti-rat integrin subunit MAbs were purchased from Becton Dick-
inson Pharmingen, San Diego, CA: Ha2/5 (b1), F11 (b3), Ha31/8 (a1), Ha1/29
(a2), and HM a5-1 (a5). MAb 15/27 was raised to a 29 amino acid peptide
from the center of the human EIIIA segment as described16. The EIIIA-spe-
ciﬁc MAb IST-9 was from Abcam, Cambridge, MA.CELL ADHESION ASSAYSFusion proteins or pFN were diluted in PBS, pH 7.4, and 50 ml aliquots
were incubated in microtiter wells in triplicate for 2 h at 37C or overnight
at 4C. After washing twice with PBS, wells were blocked with 1% BSA in
PBS for 1 h at 37C. After washing again in PBS, 75 ml aliquots of single
cell suspensions at 1.33 106/ml in Hepes buffer (10 mM Hepes, 150 mM
NaCl, 0.25% BSA, and 2 mM glucose) with or without divalent cations,
were added to the wells containing equal volumes of the same medium
with or without inhibitors. After 2 h at 37C, wells were washed three times
with appropriate Hepes buffer and adherent cells quantiﬁed by adding
100 ml of substrate/lysis solution to each well: 1% Triton X-100 (Fisher Scien-
tiﬁc, Pittsburg, PA), 6 mg/ml p-nitrophenylphosphate (PNPP) (Sigma), in
50 mM sodium acetate buffer, pH 5.0. After 45 min at 37C, the reaction
was terminated with 50 ml of 1 M NaOH, and read at 405 nm in a microtiter
plate reader (Tecan, Mannedorf, Switzerland). Adherence was expressed
as a percentage of cells originally added to each well, determined from
a standard curve generated using known numbers of cells. Absorbance
readings from blank wells were averaged and subtracted from readings ob-
tained in sample wells to subtract background.REAL-TIME POLYMERASE CHAIN REACTION (PCR)Table I
C5.18 cells exhibit significantly greater expression of chondrocyte-Reagents and apparatuses were from Applied Biosystems, Foster City,
CA, unless indicated otherwise. 5 105e2 106 cells were added to
500 ml 1X nucleic acid puriﬁcation lysis buffer, then homogenized in a Gen-
oGrinder 2000 (SpexCertiprep, Metuchen, NJ) after the addition of protein-
ase K (Invitrogen, Carlsbad, CA). Total ribonucleic acid (RNA) was
extracted using a 6100 Nucleic Acid PrepStation and coding DNA (cDNA)
was synthesized using the Quantitect Reverse Transcription kit (Qiagen).
1 ml of digested total RNA was Real-time PCR analyzed with rat glyceralde-
hyde phosphate dehydrogenase (rGAPDH) to conﬁrm digestion of all geno-
mic DNA. Rat TaqMan Gene Expression assays were used for type 1
collagen (Rn00801649_g1), type 2 collagen (Rn00563954_m1), aggrecan
(Rn00573424_m1), and rGAPDH (Rn99999916_s1). The assay for link pro-
tein (rCrtl1) was designed using Primer Express 3 by the Lucy Whittier Mo-
lecular and Diagnostic Core facility with the sequence from the listed
genebank accession number X55057 20. Each PCR reaction contained
primers at 400 nM, TaqMan probe at 80 nM, and Universal PCR Mastermix.
The default cycling conditions were used for the AB PRISM 7900 HT FAST
Real-Time PCR System. Ct values were exported with a threshold of 0.1 and
a baseline of 3e12 for the genes of interest and Gapdh.specific genes than RCJ 3.1 cells*
Type 2 collagen Aggrecan Link protein Type 1 collagenENZYME LINKED IMMUNOSORBENT ASSAYS (ELISAs)2611 2190y 551 456y 41 44 2 2These were performed as described16 using alkaline phosphatase-conju-
gated anti-GST (Sigma) or anti-his (Abcam) antibodies.*C5.18 and RCJ 3.1 cells were grown to conﬂuence over 7 days
in monolayer cultures, after which cell RNA was harvested and sub-
jected to reverse transcriptase cDNA synthesis, followed by q PCR.ANALYSIS OF DOSE-RESPONSE CURVES
Expression of three chondrocyte-speciﬁc genes (type 2 collagen,
aggrecan, and link protein) and one non-chondrocyte-speciﬁc
gene (type 1 collagen) were analyzed. To determine changes in
mRNA levels of targeted genes across multiple samples, the rela-
tive quantiﬁcation method was used. The results, representing
four experiments, are reported as the relative transcription (n-fold
difference) of each target gene for C5.18 cells in comparison to
RCJ 3.1 cells. The most stable reference gene, rGAPDH (average
cycle threshold [Ct]¼ 17.55 0.1), was used to normalize CtCurves depicting cell adhesion across varying concentrations of coating
protein were analyzed with the Ligand Binding macro in SigmaPlot 10.0
(Sigma), using the sigmoidal dose-response equation, for: (1) the concentra-
tion at which 50% of maximal cell adherence signal was attained (‘‘excitatory
concentration 50%’’ or ‘‘EC50’’), and (2) the % of applied cells that became
adherent at the maximal protein coating concentration tested (‘‘maximum %
adhesion’’ or ‘‘Max%A’’). Curves representing the optical density (OD) re-
sponse to coating protein in ELISAs were similarly analyzed for the concen-
tration at which 50% of maximal OD was achieved. EC50s were calculated
only for curves for which a sigmoid ‘‘shoulder’’ could be visualized at maxi-
mum protein coating concentrations.values of target genes, and resulting DCt values for each C5.18
cDNA sample were calibrated to the comparator RCJ3.1 cDNA
sample for each respective experiment for each target gene. TheSTATISTICS
linear amount of target molecules relative to the calibrator was cal-
culated by 2DDCt and the data is presented as the average linear-
ized value standard deviation.
yP< 0.05 for C5.18 cells in comparison to RCJ 3.1 cells.Data are presented as the average standard deviation. Statistical
analyses were performed with GraphPad Prism 4.0 (GraphPad Software,
San Diego, CA). Differences between two means were assessed by un-
paired, two-tailed Student’s t tests, except for the real-time PCR data,which was analyzed using one-tailed paired t tests. Differences among
multiple means were assessed by one-way analysis of variance, followed
by Tukey’s post hoc test.ResultsC5.18 CELLS EXHIBIT INCREASED CHONDROCYTE-SPECIFIC
GENE EXPRESSION IN COMPARISON TO RCJ 3.1 CELLSReal-time PCR was used to compare gene expression in
C5.18 and RCJ 3.1 cells that had been grown to conﬂuency
over 7 days. The C5.18 cell line exhibited signiﬁcantly
greater expression of mRNA for the chondrocyte-speciﬁc
genes encoding type 2 collagen and aggrecan, but not
type 1 collagen (Table I). Link protein expression was
also greater in C5.18 than RCJ 3.1 cells, but the difference
did not attain signiﬁcance (P¼ 0.08).C5.18 AND RCJ 3.1 CELLS ADHERE TO THE ALTERNATIVELY
SPLICED EIIIA AND V, BUT NOT EIIIB, SEGMENTS OF FNNeither C5.18 nor 3.1 cells adhered appreciably to plas-
tic surfaces coated with GST or EIIIB-GST, either in the ab-
sence or presence of cations [Fig. 2 (panel A)]. In contrast,
III-10-GST, EIIIA-GST, and V-GST each promoted cation-
dependent cell adhesion that was signiﬁcantly greater
than observed on surfaces coated with GST. For example,
in 1 mM calcium plus 1 mM magnesium (Ca/Mg), each cell
line exhibited adhesion to either III-10-GST or to V-GST
that was signiﬁcantly greater than for GST. Both cell lines
also exhibited signiﬁcant adherence to III-10 and V in the
presence of manganese (Mn), but with Mn concentration
thresholds that differed between the two segments and
two cell lines [Fig. 2 (panel A)]. In contrast, adhesion signif-
icantly exceeding GST did not occur on EIIIA-GST in Ca/
Mg, although the percent of cells that became adherent
was signiﬁcantly greater for RCJ 3.1 than C5.18 cells
(16.1 5.6% vs 2.3 1.1%, respectively, P< 0.05)
Fig. 2. C5.18 and RCJ 3.1 cell lines exhibit cation-dependent adhesion to isolated FN segments. A. Microtiter wells were coated with GST, or
GST fused to: (from left to right) EIIIB, III-10, EIIIA, and V, each at 180 nM, which promoted >90% of maximal cell adhesion for III-10-GST,
EIIIA-GST, and V-GST (see Fig. 3). C5.18 (top panels) or RCJ 3.1 (bottom panels) cells were then added to wells in the presence of adhesion
buffer containing no cations, 1 mM Ca plus 1 mM Mg (Ca/Mg), or Mn at 10, 50 or 100 mM, as described in Methods. Results are expressed as
the percent of cells applied that adhered, and represent three experiments, each performed in triplicate wells for each coating protein. For each
panel, statistical comparisons were made between cell adhesion that occurred in the presence of cations vs no cations (*), vs wells coated with
unconjugated GST under the same cationic conditions (þ), or vs the other cell line for the same coating fusion protein and cationic condition
(#). B. Microtiter wells were coated with EIIIA-GST (left panels) or V-GST (right panels) (both at 180 nM), and C5.18 or RCJ 3.1 cells were
tested for adherence, either in the absence of antibodies, or in the presence of the anti-EIIIA MAb 15/27, at ﬁnal concentrations of 1.85,
5.56, 16.67, 50, or 150 mg/ml before and during the cell adhesion process. Averaged for 4 experiments, each with triplicate wells for each
condition. Single, double, and triple comparison symbols respectively represent P 0.05, 0.01, and 0.001.
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Fig. 3. C5.18 and RCJ 3.1 cell lines both exhibit differences in adhesion to pFN in comparison to isolated segments of FN. Microtiter wells were
coated with dilution series of GST, EIIIB-GST, III-10-GST, EIIIA-GST, V-GST or rat pFN, and the percent of cells applied that became adherent
was measured. For both cell lines, pFN promoted cell adhesion at lower coating concentrations than the isolated FN segments (also see
Table II). Additionally, C5.18 cell adhesion to pFN-coated surfaces was similar in the presence of Ca/Mg as compared to Mn, whereas ad-
hesion to III-10, EIIIA, and V segments occurred at lower coating concentrations in Mn as compared to Ca/Mg. Results were averaged for
three experiments, each of which was performed with triplicate wells for each condition.
232 C. Fernandez et al.: Recognition of the alternatively spliced segments of FN[Fig. 2 (panel A)]. Nevertheless, each line adhered to EIIIA
in Mn, with C5.18 cells attaining signiﬁcant adhesion at
50 mM and RCJ 3.1 cells at 100 mM. The preferential adhe-
sion of cells to GST fusion proteins bearing FN segments
was not attributable to increased adsorbance of these pro-
teins to microtiter wells in comparison to GST, since ELISAusing anti-GST antibodies suggested greater absorption of
isolated GST per applied mole than the other proteins
(Fig. 1). Also, both cell lines adhered to his-tagged isolated
III-10 and EIIIA segments with similar cation dependency
proﬁles to those shown here for III-10-GST and EIIIA-
GST (data not shown).
Table II
Differences in adhesion-promoting capacities of the alternatively spliced segments, III-10, and pFN*
1 mM Ca/Mg 100 mM Mn
C5.18 RCJ 3.1 C5.18 RCJ 3.1
EC50 (nM) Max adherence (%) EC50 (nM) Max adherence (%) EC50 (nM) Max adherence (%) EC50 (nM) Max adherence (%)
GST e 0.3 0.7xx e 0.6 0.3 e 21.6 7.7 e 12.9 14.3
EIIIB-GST e 1.6 0.7{,zz e 1.1 2.2{ e 20.4 7.7k e 1.5 10.4{
III-10-GST 147.6 8.0{,yy 61.8 5.2x e 75.1 16.8x 37.9 9.6# 60.9 12.0x 9.0 0.2 63.0 11.9x
EIIIA-GST e 1.5 1.1{,yy e 3.5 3.1{,yy 145.2 12.6{ 37.5 2.0 156.9 75.7# 39.8 6.5
V-GST 169.2 15.8 {,yy 46.4 1.8x 199.5 114.1#,zz 66.7 10.3x,kk 21.0 10.2 43.7 6.1y 13.1 12.3 53.1 8.2z
Rat pFN 10.8 14.0 57.1 11.1x 13.1 12.1 69.4 16.1x 3.2 0.1 52.7 7.5z 2.9 0.4 59.6 9.4z
*Cell adhesion was measured in the presence of Ca/Mg or Mn in microtiter wells coated with dilution series of different GST fusion proteins or rat (pFN) and the resulting dose-response
curves were analyzed for: (1) EC50¼ the coating concentration at which 50% of maximal cell adhesion was attained, and (2) Max%A¼ the maximum percentage of cells applied that became
adherent. ‘‘e’’ indicates that the dose-response curve was not sufﬁciently sigmoid to permit calculation of EC50.
yP< 0.05 c/w GST.
zP< 0.01 c/w GST.
xP< 0.001 c/w GST.
kP< 0.01 c/w pFN.
{P< 0.001 c/w pFN.
#P< 0.05 c/w pFN.
yyP< 0.001 c/w Mn.
zzP< 0.05 c/w Mn.
xxP< 0.01 c/w Mn.
kkP< 0.05 c/w C5.18.
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234 C. Fernandez et al.: Recognition of the alternatively spliced segments of FNMn-DEPENDENT CELL ADHESION TO THE EIIIA SEGMENT IS
SPECIFIC AND MEDIATED VIA A SITE IN THE CENTRAL REGION
OF THE SEGMENTMn-dependent adhesion to the EIIIA segment by C5.18
and RCJ 3.1 cell lines was speciﬁc, since it could be
blocked by treatment of EIIIA-coated wells before and dur-
ing adhesion assays with the anti-EIIIA MAb 15/27,
whereas similar treatment of V-coated wells did not inhibit
cell adhesion, also measured in the presence of Mn
[Fig. 2 (panel B)].CELL ADHESION OCCURS AT LOWER COATING
CONCENTRATIONS OF pFN THAN ISOLATED FN SEGMENTSTo further characterize cation-dependent adhesion of
C5.18 and RCJ 3.1 cells to isolated III-10, EIIIA and V seg-
ments, and to compare these responses to those triggered
by a full-length dimeric FN, adhesion was measured in the
presence of Ca/Mg or Mn in wells coated with dilution series
of speciﬁc fusion proteins or rat pFN (Fig. 3, Table II). For
both cell lines in Ca/Mg, adhesion was evident at lower mo-
lar coating concentrations of pFN than of FN segments, with
a signiﬁcantly lower EC50 for pFN in comparison to each of
the isolated FN segments that attained sufﬁcient adhesion
to derive an EC50 (Table II). Although such differences
were less in Mn, they attained signiﬁcance for C5.18 adhe-
sion to EIIIA and III-10, and for RCJ 3.1 adhesion to EIIIA
(Table II). The capacity of Mn to stimulate greater cell adhe-
sion than Ca/Mg was also less apparent for pFN than for
isolated FN segments (Table II). For example, dose-re-
sponse curves for C5.18 adhesion to III-10, EIIIA, and V
were shifted to the left in Mn compared to Ca/Mg, whereas
the corresponding curves for pFN were essentially superim-
posable (Fig. 3). Accordingly, EC50 values for adhesion of
either cell line to V and III-10 were signiﬁcantly reduced in
Mn compared to Ca/Mg, whereas values for pFN did not dif-
fer signiﬁcantly (Table II). Among the four FN segmentsFig. 4. Recognition of the alternatively spliced EIIIA and V segments is inte
pre-incubated with anti-integrin MAbs for 30 min and then applied to micro
GST (each at 180 nM) for 2 h in the continued presence of MAb. Results a
a particular fusion protein in the absence of anti-integrin antibody. Results
using triplicate wells for each condition. (*) Ptested, the stimulatory effect of Mn was greatest for EIIIA,
which failed to support adhesion in Ca/Mg (Table II,
Fig. 3). Although C5.18 cells appeared to adhere to EIIIB-
GST in Mn, this signal was nonspeciﬁc, since a similar ef-
fect was observed for GST (Fig. 3). Despite differences in
EC50s, Max%A values obtained for either line on surfaces
coated with the III-10, V or pFN did not differ signiﬁcantly
between Ca/Mg and Mn.DIFFERENT SETS OF INTEGRIN SUBUNITS PARTICIPATE IN
C5.18 AND RCJ 3.1 CELL ADHESION TO THE EIIIA AND V
SEGMENTSTo determine which integrin subunits are required for
C5.18 and RCJ 3.1 recognition of FN segments, MAbs to
a1, a2, a5, av, b1, and b3 were tested for their capacities
to inhibit cell adhesion. For both lines, Mn-dependent adhe-
sion to EIIIA was inhibited signiﬁcantly by anti-b1 MAb.
MAbs to a2, a5, and av subunits also inhibited adhesion
by C5.18 and RCJ 3.1 cells, although these effects attained
signiﬁcance only for the latter cell line (Fig. 4).
In the presence of Ca/Mg, anti-av and anti-b3 antibodies
signiﬁcantly inhibited adhesion of each cell line to V. Adhe-
sion by C5.18 cells was additionally inhibited by MAbs to a2
and a5 subunits. In contrast, signiﬁcant inhibition of adhe-
sion to III-10 in Ca/Mg occurred only in response to anti-
a2 for C5.18 cells or anti-a5 for RCJ 3.1 cells (Fig. 4).C5.18 AND RCJ 3.1 CELLS RECOGNIZE THE ALTERNATIVELY
SPLICED V (BUT NOT EIIIB OR EIIIA) SEGMENT IN THE
CONTEXT OF III7-15 PARTIAL FNsTo determine if any of the alternatively spliced segments
of FN could be recognized by C5.18 or RCJ 3.1 cells in the
context of ﬂanking FN sequences, each cell line was tested
for its capacity to adhere to surfaces coated with recombi-
nant III7-15 partial rat FNs carrying one of these segmentsgrin dependent. C5.18 (top panels) or RCJ 3.1 (bottom panels) were
titer wells that had been pre-coated with III-10-GST, V-GST or EIIIA-
re expressed relative to the number of cells that became adherent to
are averaged for three experiments, each of which was performed
 0.05, (**) P 0.01, (***) P 0.001.
235Osteoarthritis and Cartilage Vol. 18, No. 2at its native position. Because the RGD sequence in the
10th type III repeat could potentially stimulate sufﬁcient
cell adhesion to ‘‘mask’’ recognition of a spliced segment,
we tested two sets of III7-15 FNs: one with this central
RGD sequence intact (denoted ‘‘Rþ’’), and another with it
removed (denoted ‘‘R’’)17 (Figs. 1 and 5).
Among the Rþ set, similar EC50 and Max%A values
were obtained for adhesion to SM, Bþ, Aþ and Vþ con-
structs by C5.18 or RCJ 3.1 cells in Ca/Mg (Table III).
The curves obtained for each cell line for the four constructs
in the presence of Mn were also similar. In contrast, within
the R set, the RVþ construct promoted greater C5.18
or RCJ 3.1 cell adhesion than did its SM, Bþ and Aþ coun-
terparts. This was evident as a reduced EC50 for RVþ in
comparison to the other three R constructs, attaining sig-
niﬁcance for RCJ 3.1 cells for all three comparisons in Mn
(in Ca/Mg, the curves for the three RV partial FNs
were not sufﬁciently sigmoid to obtain EC50s). The RVþ
construct also attained an increased Max%A value in com-
parison to the other three R partial FNs, with thisFig. 5. Inclusion of the alternatively spliced V segment affects cell adhesio
recognize spliced segments of FN in the context of their respective native
spliced III7-15 FNs. A. To determine if inclusion of the EIIIB, EIIIA, or V seg
Fig. 1), III7-15 FNs containing this sequence (‘‘Rþ’’), but differing in inclu
partial FN contained no alternatively spliced segments (‘‘splice minus’’ o
EIIIB (‘‘RþBþ’’), EIIIA (‘‘RþAþ’’), and V (‘‘RþVþ’’) segments. B. To a
ognition site in the 10th type III repeat, III7-15 FNs lacking this sequence (
coated in microtiter wells and the percent of cells applied that became adh
resent three experiments, each performeddifference attaining signiﬁcance for C5.18 cells in compari-
sons to RBþ in Ca/Mg, or RAþ in either Ca/Mg or Mn.
Similarly, the Max%A for RCJ 3.1 cell adhesion to RVþ
in Ca/Mg was signiﬁcantly greater than for the RBþ
construct.THE ALTERNATIVELY SPLICED V SEGMENT, IN ISOLATION OR
IN THE CONTEXT OF FLANKING FN SEQUENCES, IS
RECOGNIZED BY C5.18 AND RCJ 3.1 CELLS VIA A ‘‘SECOND’’
RGD SEQUENCETo determine whether integrin-mediated recognition of
the V segment by C5.18 or RCJ 3.1 cells could be mediated
via the ‘‘second’’ RGD sequence situated in the V95 sub-
segment (the C-terminal 95 amino acids of the V segment)
of rat FN, cells were incubated with GRGDS or irrelevant
glycine-arginine-glycine-glutamic acid-serine (GRGES)
peptide (each at 500 mg/ml) before and during cell adhesion
assays. Because the V25 subsegment (the N-terminal 25
amino acids) contains an a4 integrin-interactive EILDVn to III7-15 partial rat FNs. To test the capacity of the two cell lines to
FN ﬂanking sequences, cells were tested for adherence to variably-
ment affects recognition of the central RGD sequence in III-10 (see
sion of each of the three spliced segments, were tested. One such
r ‘‘SM’’, thus ‘‘RþSM’’), and the others respectively containing the
void interfering adhesion signals from the central RGD integrin rec-
‘‘R’’) were tested, Dilution series of the R or Rþ III7-15 FNs were
erent in the presence of Ca/Mg vs Mn was measured. Results rep-
in triplicate wells for each condition.
Table III
Effect of flanking sequences of FN upon recognition of the alternatively spliced EIIIB, EIIIA, and V segments*
1 mM Ca/Mg 100 mMMn
C5.18 RCJ 3.1 C5.18 RCJ 3.1
EC50
(nM)
Max.
adherence (%)
EC50
(nM)
Max.
adherence (%)
EC50
(nM)
Max.
adherence (%)
EC50
(nM)
Max.
adherence (%)
RþSM 7.0 3.4 58.5 6.7 19.1 17.2 82.2 17.8z 4.4 3.8 62.9 0.6 4.7 3.7 72.8 7.4
Rþ Bþ 18.9 13.5 66.1 22.0y 9.1 0.6 66.8 12.0z 15.0 10.4 60.9 16.8 4.8 3.4 69.8 15.8
Rþ Aþ 7.0 3.3 72.9 15.6y 13.1 12.4 81.4 12.8y 8.8 0.2 66.9 14.0y 6.9 3.5 73.3 8.9
Rþ Vþ 13.4 12.0 70.9 16.6 14.8 10.3 81.0 12.1 4.6 3.2 76.7 13.1 5.0 3.3 70.8 10.3
R SM e 32.1 5.2 e 32.6 13.0 26.2 16.6 45.4 13.8 34.9 15.0 63.1 2.1k
R Bþ e 22.2 5.9x e 24.0 7.9x 117.8 129.6 41.5 4.9k 46.4 16.9 60.6 15.4k
RAþ e 27.0 4.3x e 30.0 11.5 22.7 22.5 39.1 13.1x,{ 26.3 0.4 53.1 3.8k
RVþ 20.6 10.6 69.8 14.4 15.1 10.3 72.6 14.6 2.8 0.5 74.4 10.6 5.0 3.3#,yy 69.3 10.7
*Adhesion was measured in Ca/Mg or Mn in microtiter wells coated with dilution series of different III7-15 partial rat FNs containing (Rþ) or
not containing (R) the central RGD sequences in the 10th type III repeat. ‘‘SM’’ indicates ‘‘splice minus’’ or an absence of spliced segments.
‘‘B’’, ‘‘A’’ and ‘‘V’’ refer to the alternatively spliced EIIIB, EIIIA and V segments of FN. Dose-response curves were analyzed for: (1) EC50¼ the
coating concentration at which 50% of maximal cell adhesion was attained, and (2) Max%A¼ the maximum percentage of cells applied that
became adherent. ‘‘’’ indicates that the dose-response curve was not sufﬁciently sigmoid to permit calculation of EC50.
yP< 0.05 c/w identical construct minus RGD in the 10th type III repeat.
zP< 0.01 c/w identical construct minus RGD in the 10th type III repeat.
xP< 0.05 c/w RVþ.
kP< 0.05 c/w 1 mM Ca/Mg.
{P< 0.05 c/w 3.1 cells.
#P< 0.01 c/w R-SM and RAþ.
yyP< 0.001 c/w R Bþ.
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EILDV peptide. GRGDS inhibited C5.18 and RCJ 3.1 cell
adhesion to V-GST (200 nM coating concentration) by
92.4 9.4% and 87.9 6.4% respectively in Ca/Mg
(Fig. 6), whereas the corresponding values for inhibition
of adhesion to III-10-GST were 97.3 3.7% and
96.1 7.0%. In contrast, GRGES and EILDV exerted no
signiﬁcant inhibition of adhesion to V or III-10 by either
cell line (Fig. 6). Pretreatment of wells with anti-V95 rabbit
antiserum also signiﬁcantly inhibited C5.18 cell adhesion
(17.7þ 16.8% of applied cells became adherent, compared
to 70.9þ 4.1% in untreated wells, N¼ 4, P< 0.01). In con-
trast, the antiserum did not produce signiﬁcant inhibition of
adhesion to III-10, and preimmune serum had no signiﬁcant
effect upon adhesion to either protein (data not shown).
Each of the threeR- III7-15 partial FNs lacking theRGDse-
quence in III-10 in addition to the RGD-containing V segment
(R-SM, RBþ, and RAþ constructs) promoted less adhe-
sion (evident as higher EC50 values) than itsRþ counterpart,
whether measured in Ca/Mg or Mn [Fig. 5, (panels A and B),
and Table III]. Also, in comparison to the Rþ set, R III7-15
constructs generally exhibited larger differences in adhe-
sion-promoting capacity between Ca/Mg vs Mn. For exam-
ple, while the augmentation in Max%A for adhesion by
either cell line in Mn vs Ca/Mg was not signiﬁcant for any
Rþ construct, this difference attained signiﬁcance for RCJ
3.1 adhesion to R-SM, RBþ, and RAþ (Fig. 5, Table III),
and for C5.18 adhesion to RBþ (Table III).Discussion
The RCJ C5.18 (C5.18) nontransformed rat cell line
mimics chondrocyte differentiation in vitro13,15 and has
been used to evaluate the effects of a variety of signaling
molecules on this process14,21e24. To establish an in vitro
system to similarly evaluate effects of FN alternative splic-
ing on chondrocyte differentiation and chondrogenesis, weassessed the capacity of C5.18 cells to recognize the
spliced segments of FN. We have found that these cells ad-
here to (and therefore recognize) the isolated EIIIA and V
segments, but do not similarly recognize the EIIIB segment.
We also compared the FN recognition capacities of C5.18
cells to those of RCJ 3.1 cells, the multipotential chondro-
progenitor line from which C5.18 cells were cloned25,26. Al-
though differences in cation and integrin subunit
requirements for adhesion to EIIIA and V segments were
apparent, the two lines generally exhibited similar capac-
ities for FN recognition.
In addition to ‘‘inside-out’’ activation, which occurs via
talin- and kindlen-dependent pathways27, integrins can be
activated independently of intracellular signaling through
interactions of extracellular domain metal-binding sites with
Mn28,29. For example, each of the 15 constitutively ex-
pressed type III repeats of FN has been observed to support
b1 integrin-dependent cell adhesion in the presence of Mn28.
Like these unspliced repeats, the EIIIA segment was
observed in this study to trigger b1 integrin-dependent cell
adhesion in Mn but not in Ca/Mg. The relatively weak adhe-
sive activity of this segment raises the possibility that cells
could adhere to potent sequences such as the RGD domain
in III-10 and V while other segments such as EIIIA may
provide instructions that are not strictly adhesive, but might
regulate other cell functions, such as gene expression.
Our observation that cell adhesion to the EIIIA segment
requires Mn is also reminiscent of the ﬁnding that a4b1inte-
grin, which does not recognize EIIIA under basal conditions,
can be activated by Mn to do so30. Furthermore, the ab-
sence of C5.18 or RCJ 3.1 cell recognition of the EIIIA seg-
ment in the context of surrounding FN sequences is also
consistent with previous observations suggesting that cell
recognition of this segment is readily ‘‘masked’’ by sur-
rounding FN sequences17. Finally, both MAb 15/27, raised
to a synthetic 29 amino acid peptide from the center of
the EIIIA segment16, and MAb IST-9 (J. Peters, unpublished
results) blocked such adhesion, thus localizing one point of
Fig. 6. C5.18 chondrocytes and RCJ 3.1 cells both recognize the alternatively spliced V segment, either in isolation or in the context of ﬂanking
FN sequences, via a ‘‘second’’ RGD sequence. Microtiter wells were coated with V-GST or III-10-GST, or with III7-15 FNs lacking a central
RGD sequence in III-10 (‘‘R’’) that did (‘‘RVþ’’) or did not (‘‘RSM) contain the V segment (all at 200 nM). C5.18 or RCJ 3.1 cells that had
been incubated for 30 min at room temperature with synthetic GRGDSP (‘‘RGD’’), GRGESP [arginine-glycine-glutamic acid (‘‘RGE’’)], EILDV,
GRGDSþEILDV, GRGESPþEILDV, or no peptide, were added to wells in the continued presence of designated peptide and the percent of
cells applied that adhered was measured. RGD peptide produced signiﬁcant inhibition of adhesion by both cell lines to V-GST, III-10-GST,
RVþ, but not R-SM. The levels of adhesion to RVþ in the presence of RGD were less than or equivalent to adhesion to R-SM, suggesting
that most if not all of the adhesion-promoting capacity of RVþ can be relegated to RGD-inhibitable structures.
238 C. Fernandez et al.: Recognition of the alternatively spliced segments of FNrecognition of this segment to a central loop structure be-
tween C and C0 beta strands that is of recognized by a4
and a9 integrins in human systems17,30,31.
Unlike the EIIIA segment, adhesion of both cell lines to
the V segment occurred in either Ca/Mg or Mn, and was de-
pendent upon av and b3 subunits with an apparent contri-
bution of a5 and a2 subunits to recognition by C5.18
cells. Each line also readily recognized V either in isolation
or in the context of a III7-15 partial FN, and such recognition
was RGD-dependent. An anti-V95 segment antibody also
speciﬁcally inhibited C5.18 cell adhesion to V, further local-
izing a site for recognition by these cells in Ca/Mg to the
‘‘second’’ RGD sequence that is situated in the V95 subseg-
ment of rat (but not human) FN.
ELISAs with tag-speciﬁc antibodies revealed that the
EC50 for RVþ was lower than for the other R con-
structs, attaining signiﬁcance in the anti-GST ELISA. It is
therefore possible that an increased coating efﬁciency could
have contributed to the leftward shift of the cell adhesion
dose-response curve for this construct relative to the other
R constructs. However, the ELISA data also shows that
the average OD for this construct was lower than for
R-SM at a 200 nM coating concentration, indicating that
a disparity in surface adsorbance between R-SM and
RVþ constructs does not account for the results of the ex-
periments shown in Fig. 6, which were performed at
a 200 nM coating concentration. These experiments, which
show signiﬁcant preferential cell adhesion to RVþ, con-
ﬁrm that both cell lines recognize V in the context of
a III7-15 partial FN.
Based upon differential inhibition of cell adhesion by anti-
integrin MAbs, the RGD sequences in V and III-10 appear
to be recognized by different integrin receptor sets. Also, sim-
ilar to the RGD sequence in III-10, recognition of which is fa-
cilitated by a synergy site in III-97, cellular recognition of RGD
in the V segment appears to be enhanced by site(s) external
to the segment. This effect, evident as signiﬁcantly lower
EC50 values for C5.18 and RCJ 3.1 adhesion in Ca/Mg to
III7-15 RVþ (20.6 10.6 and 15.1 10.3 nM, respec-
tively) compared to V-GST (169.2 15.8 and
199.5 114.1 nM) (P< 0.001 for C5.18 and <0.01 for RCJ
3.1), did not appear to result from recognition of constitutively
expressed sequences in the RVþ construct since, as
shown in Fig. 6, V-GST promoted greater adhesion than
the R-SM III7-15 construct at equal molar coating concentra-
tions. Of note, we could not ﬁnd evidence that recognition of
the RGD sequence in III-10 is affected by inclusion of any
spliced segment in a III7-15 FN.
Included among the strengths of this study is that we
have used direct assays of cell adhesion to unambiguously
measure recognition of speciﬁc FN segments and isoforms.
Included among the limitations is that we have used anti-
body-blocking to identify FN-interactive integrin subunits.
This indirect method has left some unanswered questions,
including why anti-b1 MAb failed to block cell adhesion to
III-10 or V, despite the capacity of MAbs to a2 and a5 (b1
sub-family a subunits) to do so. Although this could be
due to a relatively weaker function-blocking capacity of
anti-b1 in comparison to anti-a subunit MAbs, a future
goal will be to corroborate these indirect observations
through direct isolation and identiﬁcation of participating
integrins on their FN segment ligands.
In summary, we have observed that C5.18 chondrocytic
cells recognize the ‘‘cartilage-restricted’’ EIIIA and V seg-
ments of FN, and we have characterized the speciﬁc cation,
integrin, and molecular context requirements for such rec-
ognition. We have also characterized FN recognition bythe RCJ 3.1 cell line, thus facilitating its use as a model to
test the effects of FN splicing on a multipotent mesenchy-
mal cell prior to chondrocyte-restriction. These ﬁndings
should facilitate the use of cell-based systems for analysis
of the effects if FN splicing on the chondrocyte differentia-
tion process in vitro.Conﬂict of interest
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